21 July 2022 : Clinical Research
Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
DOI: 10.12659/MSM.935326
Med Sci Monit 2022; 28:e935326
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
21 July 2022 : Clinical Research
DOI: 10.12659/MSM.935326
Med Sci Monit 2022; 28:e935326
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.